Drug combinations: Dangerous liaisons or great expectations?
Open Access
- 1 April 1999
- journal article
- Published by Elsevier
- Vol. 10 (4) , 375-376
- https://doi.org/10.1023/a:1008311912161
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicinAnnals of Oncology, 1999
- Incidence of Adverse Drug Reactions in Hospitalized PatientsJAMA, 1998
- In Vitro Approaches to Predicting Drug Interactions In VivoBiochemical Pharmacology, 1998
- Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer.Journal of Clinical Oncology, 1997
- Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxicAnnals of Oncology, 1996
- Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in miceBritish Journal of Cancer, 1996
- Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.Journal of Clinical Oncology, 1995